Stocktoria

BELITE BIO, INC BLTE

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2022-04-29 · LEI

BELITE BIO, INC statistics & valuation

Market cap$6.0B
P / B7.7×
Return on equity-10.1%
Return on capital-10.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20212022202320242025
Operating margin (%)
20212022202320242025
Return on equity (%)
-30.50% -35.00% -24.80% -10.10% 20212022202320242025
Shares outstanding
10.3M 24.9M 29.1M 31.8M 39.3M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-52.70% -28.60% -33.40% -23.80% -9.90% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$1.01 -$0.63 -$1.19 -$1.18 -$2.31 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Return on assets-9.9%-23.8%-33.4%-28.6%-52.7%
Return on equity-10.1%-24.8%-35.0%-30.5%64.0%
Current ratio50.0224.3124.7620.3510.66

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.